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Introduction
Urokinase plasminogen activator (uPA) plays an important role in extracellular proteolysis by generating plasmin from plasminogen. The uPA specifically binds to a cell surface receptor (uPAR) well characterized in the human system. The uPAR is a membrane protein extensively modified post-translationally. The functional, mature protein is highly glycosylated and proteolytically processed both at the amino-and carboxy-terminus. Its carboxy-terminus is further modified by the addition of a glycosylphosphatidylinositol-moiety (GPI) which anchors the receptor to the membrane surface (for review see Ref. 1) .
As reported earlier, 2 to analyze the role of uPAR in cell migration and invasion, we developed a stable transfected HOS cell line, 2A2, that demonstrates a 10-fold increase in steady-state uPAR mRNA levels and a twofold increase in surface expression of uPAR protein. For analyzing protein function in vivo, it is a standard procedure to generate stable cell lines that overexpress the protein of interest. The process of obtaining a transformed cell line is long and labor-intensive with no guarantee of finding the appropriate clone or if the selected clone will continue overexpressing indefinitely. Another limitation is that protein function can only be analyzed in the selected cell line used for the transformation. As an alternative, transiently transfected cell lines are generated using plasmids that ensure a high transcription rate. Such an approach, however, is suitable only for selected cell types that are easy to transform.
Overexpression of a protein by delivering the encoding mRNAs is a reasonable approach to bypass these transcription-related restrictions. Microinjection of in vitro transcribed mRNA is a routinely used technique for transforming relatively large frog oocytes, but it is less suitable for much smaller cultured mammalian cells. [3] [4] [5] A limited number of studies describe electroporation, DEAE-dextran transfection methods, or vehicle-free exposure of naked mRNA for introducing mRNA into mammalian cells. [6] [7] [8] [9] [10] [11] [12] Progress in this field remains slow even after technical hurdles of the mRNA delivery were eliminated by introducing cationic lipids for transfection. [13] [14] [15] [16] Overexpressing a protein in mammalian cells after administering the encoding mRNA seems to be a simple and straightforward approach with many potential applications. It is surprising, therefore, that mRNA transfection has been almost exclusively employed to express post-translationally unmodified reporter enzymes. One reason to account for this is if cell-delivered mRNA can only mediate a very low level of protein production that can be detected if the protein is a reporter enzyme, or if the protein made from exogenously delivered mRNA can not be post-translationally modified to generate a functional product. It is also possible that mRNA constructs, target cells and transfection conditions optimized to express the reporter enzymes are suboptimal for other systems.
Here, we demonstrate, to our knowledge for the first time, that in vitro transcribed mRNA delivered into mammalian cells can mediate the synthesis of a post-translationally modified receptor protein to a physiologically significant level.
Results
In vitro transcription of uPAR-encoding mRNAs To generate different uPAR-encoding mRNAs, plasmid vectors containing human uPAR cDNA flanked by different non-coding sequences were first constructed as described in Materials and methods. The linearized plasmids were used as templates for in vitro transcription reactions to generate four different mRNAs, illustrated in Figure 1a . Each mRNA contained the 1008 nt-long coding sequence of uPAR flanked by selected 5Ј and 3Ј UTRs. The ␤-globin-related UTRs are considered to provide mRNA stabilization, 13, 17 while the 5Ј-leader CITE is expected to confer cap-independent translational capability to the transcript. 18 The mRNA with CITE 5Ј-leader was uncapped because cap structure has been shown to inhibit its translation in mammalian cells.
11 Gel analysis confirmed that each transcript had the predicted size, was intact and free of contaminating DNA (Figure 1b) .
In vitro translation of uPAR mRNAs
To determine the relative translatability of the different mRNA constructs, in vitro translation was performed in rabbit reticulocyte lysate in the presence of 35 S-cysteine. Analysis of the translation products by SDS-PAGE demonstrated that each mRNA directed synthesis of the 37 kDa uPAR (Figure 2 ). The translational efficiency of the tested mRNAs was found to be equally high in two independently performed experiments. The only exception was mCITE-uPAR which usually directed a two-to threefold lower uPAR production. It is possible that conditions in this rabbit reticulocyte lysate were suboptimal for CITE-directed internal initiation of translation, which was shown to be very sensitive for various parameters such as salt concentration. 19 Incubation with the different mRNAs also led to the generation of polypeptides that were smaller than the authentic uPAR. These products probably resulted from the initiation of translation at spurious internal sites, a process characteristic of in vitro translation. 20 Stability of exogenously administered mRNA in cell culture condition To determine the stability of exogenously administered mRNA in cells and culture medium, an experiment using 3Ј-end-labeled capT7TS-uPAR-A n (capT7TS-uPAR-A n -* pCp) was performed. When HOS cells were cultured in the continuous presence of lipofectin-complexed, labeled mRNA, we determined that at 0.5, 3.0 and 20.0 h following the initiation of transfection 1.0, 4.4 and 5.8% of the radioactivity became cell-associated. Treating the cells with RNase immediately before the assays gave similar results. During the incubation, the amount of radioactivity in the medium did not change significantly. To determine if the measured radioactivities in the medium and cells were associated with intact mRNA, the samples were also analyzed by Northern assays (Figure 3 ). First, after analyzing the RNA directly, an intact band of the labeled capT7TS-uPAR-A n was detected in the medium and cells (Figure 3a) . During incubation, the capT7TS-uPAR-A n -*pCp level decreased in the medium and by 20 h, almost no intact RNA was present. Meanwhile, inside the cells, levels were highest at 3 h with significant amounts detectable at 20 h after transfection. In addition, radioactive 28S and 18S rRNAs were also present in cells isolated at 20 h following transfection. Radioactivity in the rRNAs probably arises from recycling of the labeled nucleotide from the degraded transcript. 4 It is important to note that the intracellular degradative product of capT7TS-uPAR-A n -*pCp was primarily short in size, suggesting that degradation of the mRNA likely proceeds from its 3Ј-end. This suggestion is further validated when the blots, after a complete decay of radioactivity, were hybridized with labeled uPAR cDNA ( Figure 3b ) and medium-sized degradative products were visualized. Due to the relatively rapid degradation of complexed mRNA in the medium (Figure 3 ) in all subsequent experiments, cells were treated only for 1 h with mRNA. capT7TS-uPAR-A n exhibited an 89% subpopulation more brightly stained than cells transfected with mock mRNA. This suggests 89% of the capT7TS-uPAR-A n -transfected cells overexpressed the uPA receptor. A similarly high expression frequency was reported by Lu et al 14 using ␤-galactosidase-encoding mRNA.
Translation of uPAR mRNA in mammalian cells
Radioligand binding assays were performed to determine if cell-delivered mRNA can direct the synthesis of functional uPAR (ie it is located on the cell surface and has the capacity to bind single-chain uPA (scuPA)). First, HOS cells exposed to mRNA-lipid complexes for 1 h were subsequently assayed using 125 I-scuPA. Results from a representative experiment in which all uPARencoding mRNA constructs were compared are shown in Figure 5 . At 8 h following mRNA administration capT7TS-uPAR-A n , capT7TS-uPAR and mCITE-uPAR mediated a significant increase (6.5-, 3.3-and 1.7-fold, respectively) in the level of encoded uPAR. At 24 and 48 h, however, only the capT7TS-uPAR-A n transfected cells demonstrated a significant increase (5.1-and 9.2-fold, respectively) in the cell surface-associated uPAR level. In this set of experiments, capGEM-uPAR was the only mRNA that did not significantly increase uPAR levels at any times evaluated.
Figure 4 Translational efficiency of mRNA-mediated gene transfer measured by FACS. HOS cells (1 × 10 6 ) were treated for 1 h with mock or capT7TS-uPAR-A n mRNA (2 g) complexed with lipofectin (8 g) as described in Materials and methods. FACS analysis of the cells was performed at 20 h after transfection using uPAR-specific and FITC-labeled antibodies. Shown are histograms generated by gating on 10 000 cells. The histogram obtained with capT7TS-uPAR-A n mRNA-transfected cells (filled) was overlayed on that obtained with mock mRNA-transfected cells (open). X-axis: fluorescent intensity of FITC staining in log scale; Y-axis: relative number of cells per channel analysis.

Figure 5 Specific binding of scuPA to HOS cells transfected with uPARencoding mRNAs. HOS cells (1
Data from six independently performed radioligand binding experiments summarized in Figure 6 demonstrate that HOS cells exposed to capT7TS-uPAR-A n always presented significant (up to 10.9-fold higher) levels of uPAR on their surfaces compared with mock mRNA transfected cells. Moreover, transfection with the same mRNA structure, in one experiment where cells were analyzed at a later time, a significant 3.2-fold higher uPAR level was measured at 72 h after transfection. The other mRNAs analyzed were less effective, although each mediated a significant increase in uPAR levels at 8 h after transfection in at least one of the six experiments. However, neither capT7TS-uPAR, mCITE-uPAR, nor capGEMuPAR elicited a significant effect at 24, 48, or 72 h after transfection. The variations in the increase of uPAR level, detected in independently performed experiments ( Figure 6 ), were likely due to tissue culture conditions (ie cell density), which primarily affected base-line uPAR expression. To a lesser extent, experimental differences of mRNA transfection also contributed to the variations. It is unlikely, however, that transfection-related cytotoxicity was a cause of the variation because there was no significant difference between uPAR levels in the non-transfected and mock-transfected cells (not shown).
Additional radioligand binding experiments were performed to determine if overexpression of uPAR by delivering the encoding mRNA can be accomplished in other mammalian cells as well. Results demonstrate ( Figure 7 ) that 24 h following capT7TS-uPAR-A n administration all cells expressed an increased level of uPAR. The increase with the exception of 2A2 was significant in all cell types. The 2A2 might be less responsive because their uPAR base-line level is high. The 2A2 clonal line, which was generated from HOS by stable transfection using uPAR-encoding plasmid, expressed a two-fold higher level of uPAR compared with the parental HOS cells 2 ( Figure 7) . It is possible the already high uPAR level could not be further increased to a significant level in 2A2 cells (Figure 7) . Figure  8b . At 8 h after transfection, the administered uPAR mRNAs were easily detected in the transfected cells. Their relative amounts were the same and proportional to the mRNA re-isolated from the medium used for their transfection (not shown). At 24 and 48 h after transfection, the amount of capT7TS-uPAR-A n and mCITE-uPAR was less than the level of capT7TS-uPAR and capGEMuPAR. Similar results were obtained in two other independently performed experiments. To measure physical mRNA half-lives (t 1/2 ) data obtained from the quantitative Northern blots were plotted against time as described in Materials and methods. 21 The calculated t 1/2 values were between 10.6 and 15.4 h ( 
Stability of uPAR mRNA in HOS cells
To determine if the tested uPAR-encoding mRNAs exhibit different intracellular stabilities, mRNA was reisolated from transfected HOS cells at different times after delivery and analyzed by Northern blotting. An autoradiogram of a Northern blot presented in Figure 8a was obtained from samples that were already analyzed for uPAR protein expression. Data obtained from analyzing the Northern by phosphor imaging is plotted in
Translational efficiency of uPAR-encoding mRNAs in HOS cells
To calculate stability, cellular uptake and translational efficiency of different uPAR-encoding mRNAs from data obtained in Northern and radioligand binding assays were utilized (Table 1) . Measurements of the relative amount of intact mRNA on a Northern blot containing samples from the medium (not shown) and cells ( Figure  8 ) suggest approximately 1-4% of the mRNA present in the medium was taken up by the cells. We determined the relative rate of translation for each mRNA based on the relative amounts of uPAR-encoding mRNA detectable in the cells at 8 h after transfection (Figure 8 ) and the amounts of uPAR protein measured at the same time ( Figure 5 ). The highest rate of translation (8.9-fold over pGEM-uPAR) was achieved by capT7TS-uPAR-A n . This mRNA was present in the least amount but elicited the highest uPAR protein level at 8 h after transfection (Table  1 ) and in addition, at every time-point evaluated ( Figures  5 and 8 ). Figure 5 . Figure 8b ). Calculated from mRNA levels in the medium and cells. Determined from the slopes of the graphs in which mRNA levels were plotted against time as described in the Materials and methods (R: fitting of the slope). d uPAR level ± s.d. at 8 h after transfection (data from Figure 5 ). e Determined by dividing the amount of uPAR with the amount of encoding mRNA at 8 h after transfection, shown the values relative to those obtained with capGEM-uPAR.
Figure 8 Northern blot analysis of mRNA isolated from mRNA-transfected cells. HOS cells (1 × 10 5 ) were treated for 1 h with in vitro transcribed mock and uPAR mRNAs (0.2 g) complexed with lipofectin (0.8 g). At the indicated time following transfection, cells were analyzed in ligand-binding assay as described in Materials and methods and the result is shown in
Then, total RNAs were isolated from the assayed samples and their aliquots analyzed by Northern assay using labeled uPAR cDNA as probe. (a) RNA samples isolated from cells transfected with mock (lanes 1, 6 and 11), capT7TS-uPAR-A n (lanes 2, 7 and 12), capT7TS-uPAR (lanes 3, 8 and 13), capGEM-uPAR (lanes 4, 9 and 14) and capCITE-uPAR (lanes 5, 10 and 15) are shown. Autoradiogram demonstrates the presence of the intact mRNAs intracellularly at the indicated time following transfection. (b) Quantification of the Northern blot using phosphor image analysis.
Discussion
Data presented here illustrate that mammalian cells exposed to in vitro transcribed uPAR mRNA can express the encoded protein in its functional, post-translationally modified form. The uPAR level increased 10-fold and overexpression was detectable in approximately 90% of the transfected cells. The magnitude and duration of uPAR expression depended on the untranslated regions of the mRNA. The capped and polyadenylated transcript with ␤-globin 5Ј and 3Ј UTRs presented the highest translation rate. Using this mRNA, significant overexpression of the encoded protein was detectable from 8 and up to 72 h after transfection. During the first cationic lipid-mediated mRNA delivery into mammalian cells, Malone et al 13 documented and subsequent studies confirmed, 14, [22] [23] [24] that ␤-globin 5Ј and 3Ј UTRs and poly(A) tail substantially enhance the translation efficiency of the exogenously administered mRNA. In these reports, although not shown, these elements were suggested to elicit their effect by increasing the mRNA stability. A similar conclusion was drawn in early studies based primarily on translational performance of polyadenylated versus de-adenylated ␤-globin mRNAs microinjected into frog oocytes or cultured mammalian cells. 3, 4, 17 Here, using uPAR-encoding transcripts, we also demonstrated that capT7TS-uPAR-A n , the mRNA with ␤-globin 5Ј and 3Ј UTRs and poly(A) tail can direct uPAR expression highest in magnitude and duration. However, using direct Northern analysis, we demonstrated the intracellular stability of all tested uPAR mRNA, independently of whether they were capped or polyadenylated, was about equal (Figure 8 , Table 1 ). Although both cap and poly(A) tail is considered to stabilize mRNA, studies suggest these elements actually play a minor or no role in stabilizing mRNA within higher eukaryotes. 4, 7, [25] [26] [27] [28] Therefore, these elements more likely increase translational rate rather than stability of the RNA. 4, 7, 28 A recent study estimates that the endogenous uPAR mRNA half-life is 3 h. 29 This short half-life was due to a protein which labilizes uPAR mRNA by specifically binding to its coding region. In the present study, we have measured a relatively long 10.6-15.4 h intracellular halflives for the administered uPAR mRNA (Table 1) . Although it has not been determined, it is possible the protein that labilizes uPAR mRNA, like other proteins controlling mRNA stability (eg AU-rich element binding protein 30 ), becomes associated with the mRNA in the nucleus. Consequently, uPAR mRNA generated in the nucleus will associate with the labilizing protein and degrade rapidly, while the same mRNA transcribed in vitro and delivered to the cytoplasm will have a prolonged half-life. This suggests in vitro transcribed mRNA delivered into the cells could have an extended half-life compared with mRNA transcribed in vivo.
We determined, by quantifying Northern blots, 1.4-3.6% of administered mRNA was cell-associated at 8 h after transfection (Table 1 ). The level of each delivered mRNA was significantly less at 24 compared with 8 h (Figure 8 ). When, like others, 13 we used labeled mRNA and direct measurements of radioactivity, we also detected a higher delivery rate and the incorporation seemed to increase over time. This is, however, probably a gross overestimation of the delivery rate because the calculation includes labeled degradative and reincorporated products also present in the cells (see Figure 3a) . Therefore, measuring the level of intact mRNA rather than total radioactivity is important for an accurate mRNA uptake determination.
Based on reports by us and others, we can only speculate as to why, despite its superior characteristics, mRNA-mediated transfection has not been widely used to transform mammalian cells. First, selecting the appropriate non-coding sequence is one of the most critical factors for making mRNA transfection successful. [22] [23] [24] 31 Usually, the most potent mRNAs have long, non-structured UTRs and poly(A) tails. Under special circumstances (eg mRNA which requires transport before translation) mRNAs without poly(A) tail has been reported to be more potent 32, 33 since the mRNAs will move faster than their polyadenylated counterparts. 4 Second, selecting the most effective, non-toxic mRNA delivery method is also very important. Our efforts to express a protein after delivering the encoding mRNA were not successful until we established an adequate delivery method. 16 Third, a clean mRNA preparation is necessary for achieving high translation levels from the delivered mRNA. The preparation must be free of template DNA and transcription by-products, like dsRNA. These contaminants, even in small quantities, can activate dsRNA-dependent kinase to phosphorylate eIF2, resulting in the shut-down of protein synthesis. [34] [35] [36] Here, we provide evidence for the feasibility of mRNAmediated transfection by demonstrating in vitro transcribed mRNA delivered into mammalian cells can mediate the synthesis of a post-translationally modified receptor protein to a physiologically significant level. The non-coding sequence of the mRNA was one of the most critical factors for determining the level and duration of the encoded receptor. The capped, poly(A)-tailed mRNA with ␤-globin-related 5Ј and 3Ј UTRs provided the highest translational rate. The technique described in this study can serve as a model system for analyzing protein function in vivo.
Materials and methods
Cell cultures
The following cell lines were obtained from American Type Culture Collection (ATCC, Rockville, MD, USA): COS, HOS, CHO (DHFR −/− ) and NIH3T3. 2A2, an HOS cell line overexpressing uPAR was generated as described. 2 Transformed human kidney carcinoma (293T) was obtained from Dr Ron Collman (University of Pennsylvania, Philadelphia, PA, USA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS).
Plasmids
For mRNA transfections, we employed synthetic mRNA transcripts obtained by in vitro synthesis. Template plasmids were generated by subcloning the uPAR cDNA from pGEM-uPAR, obtained by RT-PCR cloning as described. 2 For construction of pT7TS-uPAR, plasmid pT7TS (provided by Dr Paul Krieg, University of Texas, Austin, TX, USA) containing the corresponding 5Ј and 3Ј UTR sequences of Xenopus ␤-globin mRNA and a stretch of dA 30 dC 30 was used as described. 37 To construct pCITEuPAR, uPAR cDNA was amplified in high fidelity PCR using UlTma DNA polymerase (Perkin-Elmer, Norwalk, CT, USA) and pGEMuPAR as the template. For priming, 5Ј primer (5Ј GTCACCCGCCGCTGCTG 3Ј) corresponding to nt 51-67 of the uPAR cDNA and 3Ј primer (5Ј GCCATTCGCCATTCAGG 3Ј) corresponding to nt 2562-2578 of plasmid pGEM-3z (Promega, Madison, WI, USA) were used (GenBank, Accession: X51657 and X65304, respectively). The PCR product was cut with SalI and inserted into the MscI/SalI site of the pCITE2b plasmid (Novagen, Madison, WI, USA) which contained the 5Ј non-coding region of encephalomyocarditis virus (EMCV) RNA functioning as a cap-independent translation enhancer (CITE). To obtain mock mRNA, we used pT7-TEV-luc-A 50 , 8 a gift from Dr Daniel Gallie, University of California, Riverside, CA, USA. This vector contained the coding sequence of firefly luciferase. Plasmids were purified using the Qiagen kit (Qiagen, Santa Clarita, CA, USA), quantified spectrophotometrically and sequenced.
In vitro transcription
Transcriptions were performed according to the manufacturer by incubating 2 g linearized plasmid template in a final 20 l reaction mix using MegaScript or MessageMachine kits (Ambion, Austin, TX, USA) to generate uncapped or m 7 GpppG-capped mRNAs, respectively. Plasmid pT7TS-uPAR was linearized with either SpeI or XbaI to cut at the 3Ј-or 5Ј-end of the incorporated stretch of ␤-globin-specific 3ЈUTR and dA 30 dC 30 . The templates and T7 RNA polymerase were then used to synthesize the capped transcripts capT7TS-uPAR-A n and capT7TS-uPAR, with or without poly(A) tail, respectively. The 5Ј UTRs were 73 nt-long in both mRNAs, but the 3Ј UTR of capT7TS-uPAR was 55 nt-long. The 3Ј UTR of capT7TS-uPAR-A n was 289 nt-long and included the ␤-globin (212 nt), poly(A)-tail (30 nt) specific, and plasmidrelated sequences. The capGEM-uPAR was similarly transcribed using EcoRI-linearized pGEMuPAR template and SP6 RNA polymerase. The lengths of its 5Ј and 3Ј UTRs were 15 and 47 nt, respectively. The uncapped mCITEuPAR was transcribed from Bgl II-linearized pCITE-uPAR using T7 RNA polymerase. The mCITE-uPAR contained a 518 nt-long 5Ј UTR and 95 nt-long 3Ј UTR. The mock mRNA, capTEV-luc-A 50 , was generated as described. 16 Purification of the transcripts were performed by DNase I digestion followed by LiCl precipitation and 75% ethanol wash. At least three different batches of mRNA were generated and used. The quality of each batch of mRNAs was tested by agarose gel electrophoresis for degradation and the presence of contaminating DNA template. RNA samples were quantified by measuring optical density at 260 nm. Samples were stored in siliconized tubes at −20°C in 0.5-1.0 g/l final concentrations.
In vitro translation
Nuclease-treated rabbit reticulocyte lysate (Ambion), optimized for preferential translation of capped mRNA, was used. Aliquots (12.5 l) of the lysate containing 
Transfection of cells
Plates with 96 or 12 wells were seeded with 5 × 10 4 or 5 × 10 5 cells per well 1 day before transfection. The lipofectin (Gibco BRL, Gaithersburg, MD, USA) mRNA complex was assembled as described. 16 For transfecting cells in 96-well plates, 0.2 g mRNA complexed with 0.8 g lipofectin in a 50 l final volume was used for each well. From the same complex, 500 l was used when cells in 12-well plates were transfected. The transfection mix was added directly to the cell monolayers from which the culture medium was removed. Cells were incubated with the transfection mixture for 1 h at 37°C in a 5% CO 2 incubator. The mixture was then replaced with fresh, prewarmed culture medium supplemented with 10% FCS and further incubated.
Radioligand binding assay
Single-chain urokinase-type plasminogen activator (scuPA; provided by Dr Jack Henkin, Abbott Laboratories, Abbott Park, IL, USA) was radiolabeled as we described. 38 Firstly, cells plated in 96-well plates were transfected with different uPAR-encoding and mock mRNAs at 8, 24, 48 and 72 h before performing the radioligand binding assay. Then, cells were incubated with 125 I-labeled scuPA (10 nm, specific activity 1 × 10 5 d.p.m./pmol) at 4°C for 2 h with or without a 50-fold molar excess of unlabeled scuPA as a measure of total and nonspecific binding, respectively. The cells were then washed five times with Dulbecco's phosphate buffered saline containing 3 mg/ml BSA (PBS-BSA). Cells were removed from the plate by lysing them in 50 l guanidinium thiocyanate (RNazol, Biotecx Laboratories, Houston, TX, USA), and the cell-associated radioactivity was counted (these lysates were subsequently used for RNA isolation). Specific binding was defined as the difference between total binding and nonspecific binding. At least three independent experiments were performed in triplicate.
Northern analysis
The 50 l HOS cell lysates that have been used to measure uPAR level in radioligand binding assays were further utilized for total RNA isolation performed according to Chomczynski and Sacchi. 39 RNA, containing uPAR-specific mRNAs taken up by the cells and total cellular RNA, were precipitated in the presence of 4 g glycogen carrier. RNA was also isolated from aliquots (5 l) taken from each of the transfection mixes before administering it to cells. Transfection mix-associated RNAs were also precipitated in the presence of 4 g glycogen carrier. One quarter of the isolated RNA was denatured in the presence of 2 g carrier RNA isolated from rat brain then separated in denaturing, 1.4% agarose, 0.22 m formaldehyde gels. Addition of carrier RNA was essential for efficient sample separation in the gel. RNAs transferred to NYTRAN Plus filters (Schleicher and Schuell, Keene, NH, USA) were UV cross-linked. The filters were prehybridized at 42°C for 2 h in 1 × Northern hybridization buffer (5 Prime → 3 Prime, Boulder, CO, USA) containing 50% (v/v) deionized formamide (Clontech Laboratories, Palo Alto, CA, USA). To probe the Northern blots, 50 ng DNA corresponding to the uPAR-encoding region was labeled using Redivue ␣-32 PdCTP (Amersham) and a random prime labeling kit (Boehringer Mannheim, Indianapolis, IN, USA). The filters were hybridized at 42°C for 12-16 h with the prehybridization solution containing the labeled and denatured probe. The filters were washed and exposed to Kodak MS film using an MS intensifier screen at −70°C for 1-24 h. Northern blots were quantified by Phosphor Screen Imaging (Storm 860, Molecular Dynamics, Sunnyvale, CA, USA) using image analysis program (Molecular Analyst, Bio-Rad Laboratories, Hercules, CA, USA). The halflife of mRNA (t 1/2 ) was defined as t 1/2 = 0.693/k, where k = 2.303 × slope of the best-fit line through the data points of a graph which was generated by plotting the log 10 of the arbitrary values (obtained by quantifying the Northern blot) against time. 21 Labeling the mRNA To generate 3Ј-end-labeled mRNA, capT7TS-uPAR-A n (1 m) was ligated to 32 P-pCp (1 m, spec act 3000 Ci/mmol; NEN, Boston, MA, USA) using 2 units/l T4 RNA ligase (Gibco BRL) in 15 l final volume for 16 h at 4°C as recommended. 40 The labeled product (capT7TS-uPAR-A n -*pCp) was precipitated in the presence of 10 g carrier tRNA (Gibco BRL) using NaOAc (0.3 m) and ethanol (2.5 volume). Reconstituted sample was analyzed by Northern blotting followed by direct detection. Radioactivity was detectable only on the Nylon membrane and not on the blotting papers used for the capillary transfer. 
